Published in World J Gastroenterol on August 01, 2001
Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. PLoS One (2012) 1.24
Clinical benefit of liver stiffness measurement at 3 months after Kasai hepatoportoenterostomy to predict the liver related events in biliary atresia. PLoS One (2013) 0.85
Supersonic shearwave elastography in the assessment of liver fibrosis for postoperative patients with biliary atresia. Sci Rep (2016) 0.75
Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet (1993) 8.54
The treatment of portal hypertension: a meta-analytic review. Hepatology (1995) 3.11
A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology (1989) 2.40
Bacterial infection in the pathogenesis of variceal bleeding. Lancet (1999) 2.35
Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit. Crit Care Med (1988) 2.33
Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med (1992) 2.31
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology (1999) 2.18
Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med (1993) 2.16
Prospective randomized trial of emergency portacaval shunt and emergency medical therapy in unselected cirrhotic patients with bleeding varices. Hepatology (1994) 2.08
Sclerotherapy for actively bleeding esophageal varices in male alcoholics with cirrhosis. Veterans Affairs Cooperative Variceal Sclerotherapy Group. Gastrointest Endosc (1997) 2.05
Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology (1990) 2.02
"Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology (1998) 1.95
Prognostic factors in upper G.I. bleeding. Endoscopy (1986) 1.94
Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet (1993) 1.82
A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol (1999) 1.76
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol (2000) 1.66
Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology (1999) 1.64
Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group. Gastroenterology (1996) 1.64
Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology (1998) 1.60
Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology (1998) 1.57
A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol (1995) 1.52
Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience. Gastrointest Endosc (1997) 1.52
Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci (1988) 1.40
N-butyl-2-cyanoacrylate: a supplement to endoscopic sclerotherapy. Endoscopy (1987) 1.31
Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial. Gastroenterology (1975) 1.28
Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology (1996) 1.28
Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med (1995) 1.21
Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial. Hepatology (1995) 1.21
Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates. Hepatology (1989) 1.21
Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence. J Hepatol (1997) 1.16
The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices. Endoscopy (1995) 1.15
A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. J Hepatol (1992) 1.15
Balloon tamponade in variceal bleeding: use and misuse. BMJ (1989) 1.13
Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage. Br J Surg (1986) 1.13
Clinical implications of the white nipple sign and its role in the diagnosis of esophageal variceal hemorrhage. Am J Gastroenterol (1996) 1.12
Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol (1998) 1.11
Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial. J Hepatol (1993) 1.10
A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med (1989) 1.10
Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology (1997) 1.08
A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology (1995) 1.07
Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol (1998) 1.07
N-butyl-2-cyanoacrylate (Histoacryl) plus sclerotherapy versus sclerotherapy alone in the treatment of bleeding esophageal varices: a randomized prospective study. Endoscopy (1995) 1.06
Successful therapy of bleeding duodenal varices by TIPS after failure of sclerotherapy. Am J Gastroenterol (1998) 1.05
Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis. BMJ (1995) 1.05
Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. J Hepatol (2000) 1.05
Transjugular intrahepatic portosystemic shunting: decreased survival for patients with high APACHE II scores. Am J Gastroenterol (1995) 1.04
Desmopressin and bleeding time in patients with cirrhosis. Br Med J (Clin Res Ed) (1985) 1.03
Emergency transjugular intrahepatic portasystemic stent shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg (1994) 1.02
Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet (1995) 1.02
Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology (1989) 0.98
Randomized trial of portacaval shunt, stapling transection and endoscopic sclerotherapy in uncontrolled variceal bleeding. J Hepatol (1987) 0.97
A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding. Hepatology (1994) 0.97
Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding. Am J Gastroenterol (1998) 0.96
Prognostic significance of the white nipple sign in variceal bleeding. Gastrointest Endosc (1991) 0.94
A prospective reappraisal of emergency endoscopy in patients with portal hypertension. Scand J Gastroenterol (1982) 0.94
Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting. Hepatology (1989) 0.93
Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure. Gastroenterology (1991) 0.92
A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage. Gut (1997) 0.92
Acute hemoperitoneum after large-volume paracentesis. Gastroenterology (1997) 0.91
Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol (1990) 0.91
Selective intra-arterial vasopression in fusion for upper gastrointestinal tract hemorrhage: a controlled trial. Arch Surg (1980) 0.91
Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol (1989) 0.90
Esophageal transection versus injection sclerotherapy in the management of bleeding esophageal varices in patients at high risk. Surg Gynecol Obstet (1985) 0.90
Hepatorenal syndrome. Long-term treatment with terlipressin as a bridge to liver transplantation. Dig Dis Sci (1996) 0.90
Transjugular intrahepatic portosystemic shunt in the treatment of intermittently bleeding stomal varices. Am J Gastroenterol (1996) 0.89
Continuous intravenous vasopressin in active upper gastrointestinal bleeding. Ann Intern Med (1982) 0.89
Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome. J Hepatol (1996) 0.88
Effect of intravenously administered posterior pituitary extract on hemorrhage from bleeding esophageal varices. A controlled evaluation. N Engl J Med (1962) 0.88
Prediction of outcome following acute variceal haemorrhage. Br J Surg (1985) 0.87
Massive bleeding from ileal conduit peristomal varices: successful treatment with the transjugular intrahepatic portosystemic shunt. J Urol (1998) 0.87
Response to dopamine hydrochloride in the hepatorenal syndrome. Arch Intern Med (1975) 0.86
Limitations of multiple injection sclerotherapy sessions for acute variceal bleeding. S Afr Med J (1986) 0.86
Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study. Hepatology (1986) 0.86
Transjugular portosystemic shunt for treatment of bleeding stomal varices. Dig Dis Sci (1997) 0.86
Terlipressin may influence the outcome of hepatorenal syndrome complicating alcoholic hepatitis. Am J Gastroenterol (1997) 0.86
Endoscopic sclerotherapy versus esophageal transection of Child's class C patients with variceal hemorrhage. Comparison with results of portacaval shunt: preliminary report. Surgery (1982) 0.84
Rectal variceal bleeding treated by transjugular intrahepatic portosystemic shunt. Potentials and pitfalls. J Clin Gastroenterol (1997) 0.84
Malnutrition in cirrhotic patients: anthropometric measurements as a method of assessing nutritional status. Br J Clin Pract (1990) 0.83
Emergency endoscopy strategies for improved outcomes. Scand J Gastroenterol Suppl (1998) 0.80
Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in portal hypertension: comparison of emergency and elective interventions. Dig Dis Sci (1998) 0.80
Correction of both prothrombin time and primary haemostasis by recombinant factor VII during therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis. J Hepatol (1999) 0.79
Transjugular intrahepatic portosystemic shunt creation in children: initial clinical experience. Radiology (1998) 0.78
Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy. Scand J Gastroenterol (1989) 0.78
Transjugular portosystemic shunts in pediatric patients awaiting liver transplantation. Transplantation (1996) 0.77
Impact of aprotinin on blood transfusion requirements in liver transplantation. Transfus Med (1993) 0.76
Emergency transjugular intrahepatic portosystemic shunt prior to liver transplantation. Pediatr Radiol (1997) 0.76
Which is the factual basis, in theory and clinical practice, for the use of fresh frozen plasma? Vox Sang (1978) 0.76
Transjugular intrahepatic portosystemic shunt in an infant. Pediatr Radiol (1997) 0.76
Endoscopic sclerotherapy with fibrin glue as compared with polidocanol to prevent early esophageal variceal rebleeding. J Hepatol (1998) 0.76
Emergency transjugular intrahepatic portosystemic shunt (TIPS) in an infant: a case report. J Pediatr Surg (1997) 0.76
Abnormal hemoglobin-oxygen affinity and surgical hemotherapy. Bibl Haematol (1980) 0.75
Prospective study on the application of the Baveno II Consensus Conference criteria in patients with cirrhosis and gastrointestinal bleeding. J Hepatol (2000) 0.75
First interim analysis of the GIDEON (Global Investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafeNib) non-interventional study. Int J Clin Pract (2012) 1.65
GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis. Int J Clin Pract (2013) 1.41
[Statistics on basocellular carcinoma in Londrina, Paraná, Brazil]. Bol Oficina Sanit Panam (1982) 1.37
Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point? Gut (2002) 1.01
Acute jaundice. Clin Med (2001) 0.75